Gleamer vs Rayscape

Last VerifiedAugust 4, 2026
Verdict

Two European radiograph companies reading different films for different departments. Gleamer is trauma first, detecting fractures, effusions and dislocations with a clearance covering adult and paediatric use that is reported to be unique in that segment, aimed at the overnight emergency queue where a missed finding most reliably becomes a complaint. Rayscape is chest first, with a large findings set, longitudinal comparison against prior scans and independent evaluation from a tuberculosis screening deployment. A department choosing between them is choosing which reading burden to attack rather than which vendor is better. Ask each for performance on your own case mix, because prevalence changes the false positive burden more than published sensitivity does.

Select Gleamer if
  • Its fracture detection clearance covers both adult and paediatric use, reported to be unique in that segment, with a strong clearance study design behind it.
  • Trauma radiography is the highest volume plain film reading in any emergency department and the one where a missed finding most often becomes a claim.
  • Distribution runs directly and through several imaging platform partners, so adoption does not depend on one integration path.
Select Rayscape if
  • Chest coverage is broad with longitudinal comparison against a patient's prior scans, plus lung nodule work on computed tomography.
  • Independent evaluation in a tuberculosis screening context is a harder test than a retrospective reader study.
  • On premise and cloud integration are both offered, which matters where images cannot leave the institution.
Attribute Matrix

Side by Side

Axis
G
Gleamer
R
Rayscape
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.

Disclosure

Compare these per body region and per finding rather than on aggregate claims, since a trauma product and a chest product share almost no performance surface and their findings counts are not comparable. Neither publishes a security attestation or trust centre, which this index records as a pattern across non United States imaging vendors rather than a fault of either. Gleamer's multi party distribution makes data stewardship harder to answer, since the responsible party varies by delivery path and no business associate terms were located.

AI Health Index

An independent reference for evaluating AI vendors in healthcare. No vendor pays for inclusion, placement, or rating.

Index Status
Last index update
August 4, 2026
The AI Health Index is an editorial reference, not a regulatory body. Vendor data is verified against published sources and public regulatory filings. Figures labeled “Estimated” have not been confirmed by the vendor. See the Methodology page for evaluation standards and limitations.
© 2026 AI Health Index
3801 N Capital of Texas Hwy, Ste E240 · Austin, TX 78746